China Resources Medical Holdings
Market Cap
HK$5.4b
Last Updated
2020/04/09 13:14 UTC
Data Sources
Company Financials +
Executive Summary
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People’s Republic of China.
Snowflake Analysis
Excellent balance sheet and slightly overvalued.
Similar Companies
Share Price & News
How has China Resources Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1515's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
4.5%
1515
4.8%
HK Healthcare
3.6%
HK Market
1 Year Return
-29.0%
1515
-37.0%
HK Healthcare
-18.5%
HK Market
Return vs Industry: 1515 exceeded the Hong Kong Healthcare industry which returned -38.6% over the past year.
Return vs Market: 1515 underperformed the Hong Kong Market which returned -20.6% over the past year.
Shareholder returns
| 1515 | Industry | Market | |
|---|---|---|---|
| 7 Day | 4.5% | 4.8% | 3.6% |
| 30 Day | 10.0% | -5.7% | -3.8% |
| 90 Day | -3.5% | -23.2% | -13.2% |
| 1 Year | -27.5%-29.0% | -35.6%-37.0% | -15.5%-18.5% |
| 3 Year | -55.4%-57.0% | -45.4%-48.7% | 0.7%-9.5% |
| 5 Year | -68.9%-70.6% | -52.4%-54.5% | -14.0%-27.8% |
Price Volatility Vs. Market
How volatile is China Resources Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Are China Resources Medical Holdings Company Limited's (HKG:1515) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?2 weeks ago | Simply Wall St
CN¥4.99: That's What Analysts Think China Resources Medical Holdings Company Limited (HKG:1515) Is Worth After Its Latest Results2 weeks ago | Simply Wall St
Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?Valuation
Is China Resources Medical Holdings undervalued compared to its fair value and its price relative to the market?
12.83x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 1515 (HK$4.39) is trading above our estimate of fair value (HK$4.04)
Significantly Below Fair Value: 1515 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1515 is good value based on its PE Ratio (12.8x) compared to the Healthcare industry average (13.4x).
PE vs Market: 1515 is poor value based on its PE Ratio (12.8x) compared to the Hong Kong market (9.4x).
Price to Earnings Growth Ratio
PEG Ratio: 1515 is poor value based on its PEG Ratio (1.3x)
Price to Book Ratio
PB vs Industry: 1515 is good value based on its PB Ratio (0.9x) compared to the HK Healthcare industry average (1.2x).
Next Steps
Future Growth
How is China Resources Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
9.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1515's forecast earnings growth (9.9% per year) is above the savings rate (1.6%).
Earnings vs Market: 1515's earnings (9.9% per year) are forecast to grow slower than the Hong Kong market (11.8% per year).
High Growth Earnings: 1515's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1515's revenue (6.6% per year) is forecast to grow slower than the Hong Kong market (9.7% per year).
High Growth Revenue: 1515's revenue (6.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1515's Return on Equity is forecast to be low in 3 years time (8%).
Next Steps
Past Performance
How has China Resources Medical Holdings performed over the past 5 years?
17.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1515 has high quality earnings.
Growing Profit Margin: 1515's current net profit margins (18.5%) are lower than last year (20.9%).
Past Earnings Growth Analysis
Earnings Trend: 1515's earnings have grown by 17.6% per year over the past 5 years.
Accelerating Growth: 1515's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1515 had negative earnings growth (-9.3%) over the past year, making it difficult to compare to the Healthcare industry average (7%).
Return on Equity
High ROE: 1515's Return on Equity (6.5%) is considered low.
Next Steps
Financial Health
How is China Resources Medical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 1515's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 1515's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥349.6M).
Debt to Equity History and Analysis
Debt Level: 1515's debt to equity ratio (9.4%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 1515's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 1515's debt is well covered by operating cash flow (40.5%).
Interest Coverage: 1515 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is China Resources Medical Holdings's current dividend yield, its reliability and sustainability?
2.25%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: 1515's dividend (2.25%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.56%).
High Dividend: 1515's dividend (2.25%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.14%).
Stability and Growth of Payments
Stable Dividend: 1515 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 1515's dividend payments have increased, but the company has only paid a dividend for 6 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (28.9%), 1515's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 1515's dividends in 3 years are forecast to be well covered by earnings (30% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.5yrs
Average management tenure
CEO
Libing Cheng (55yo)
1.67s
Tenure
CN¥5,352,000
Compensation
Mr. Libing Cheng serves as Vice President of Phoenix Healthcare Group Co. Ltd. Mr. Cheng served as an Executive General Manager at Phoenix Healthcare Group Co. Ltd. since March 2013. Mr. Cheng joined Phoen ...
CEO Compensation Analysis
Compensation vs Market: Libing's total compensation ($USD757.56K) is above average for companies of similar size in the Hong Kong market ($USD492.61K).
Compensation vs Earnings: Libing's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 1.67yrs | CN¥5.35m | 0.11% CN¥5.8m | |
| Vice Chairman | 1.67yrs | no data | no data | |
| CFO & Executive Director | 2.5yrs | CN¥2.24m | no data | |
| Deputy GM & Executive Director | 2.5yrs | CN¥3.17m | 0.028% CN¥1.5m | |
| Executive General Manager | 3.33yrs | CN¥2.92m | no data | |
| Chief General Counsel & Board Secretary | no data | no data | no data | |
| Company Secretary | 1.75yrs | no data | no data |
2.5yrs
Average Tenure
46yo
Average Age
Experienced Management: 1515's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 1.67yrs | CN¥5.35m | 0.11% CN¥5.8m | |
| Vice Chairman | 1.67yrs | no data | no data | |
| CFO & Executive Director | 2.5yrs | CN¥2.24m | no data | |
| Deputy GM & Executive Director | 2.5yrs | CN¥3.17m | 0.028% CN¥1.5m | |
| Independent Non-Executive Director | 2.08yrs | CN¥199.00k | no data | |
| Honorary Chairman | 3.42yrs | no data | no data | |
| Non-Executive Director | 3.42yrs | no data | no data | |
| Independent Non-Executive Director | 6.58yrs | CN¥422.00k | no data | |
| Independent Non-Executive Director | 4.67yrs | CN¥240.00k | no data | |
| Independent Chairman | 1.67yrs | CN¥358.00k | no data |
3.0yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 1515's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
China Resources Medical Holdings Company Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: China Resources Medical Holdings Company Limited
- Ticker: 1515
- Exchange: SEHK
- Founded: 2007
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: HK$5.446b
- Shares outstanding: 1.30b
- Website: https://www.crmedical.hk
Number of Employees
Location
- China Resources Medical Holdings Company Limited
- E-825, No. 6 Taiping Street
- Xicheng District
- Beijing
- 100050
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 1515 | SEHK (The Stock Exchange of Hong Kong Ltd.) | HKD0.00025 | HK | HKD | No data | |
| 1515 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Nov 2013 |
| 1PH | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Nov 2013 |
| 1515 | SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect) | Yes | Ordinary Shares | HK | HKD | Nov 2013 |
| 1515 | SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect) | Yes | Ordinary Shares | HK | HKD | Nov 2013 |
Biography
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People’s Republic of China. The company also engages in group purchasing organization business and other hospital-derived services. In addition, it manages third-party hospitals and clinics under the invest-operate-transfer (IOT) model. In addition, it is involved in supply chain business, including the sale of pharmaceuticals, medical devices, and medical consumables and equipment. The company was formerly known as China Resources Phoenix Healthcare Holdings Company Limited and changed its name to China Resources Medical Holdings Company Limited in October 2018. The company was founded in 2007 and is headquartered in Beijing, the People’s Republic of China.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/04/09 13:14 |
| End of Day Share Price | 2020/04/09 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.